Ectopic Pregnancy Flashcards
Ectopic Diagnosis
HCG Rise 53% in 48 hours
Discriminatory Zone 1500
-Don’t use for IVF or ovulation induction
Date of pregnancy Discriminatory zone 38 days after menses
Miscarriage
Gest sac of 25 mm without yolk sac or
fetal pole confirms anembryonic
pregnancy (blighted ovum)
CRL of 7 mm without FHM confirms embryonic demise (missed Ab)
Methotrexate
Antimetabolite, interrupts
synthesis of purine nucleotides
(folic acid antagonist)
• Metabolized in the kidney
Who can use Methotrexate?
Hemodynamically stable • With no signs of ruptured adnexal mass • Able to comply with follow-up care - desires fertility - coexisting IUP • Without contraindications to MTX
Absolute contraindications:
- Breastfeeding
- Evidence of immunodeficiency
- Alcoholism, liver disease
- Pre-existing blood dyscrasias or anemia
- Hepatic, renal or hematologic dysfunction
- Active pulmonary disease, or peptic ulcer
- Known sensitivity to MTX
Relative contraindications:
- Gestational sac 3.5 cm-4 cm
- Fetal cardiac motion
- HCG>5000
Baseline Testing prior to MTX and Patient instructions
• Baseline tests:
- CBC, LFTs, creatinine, Rh
• Patient instruction: 1. No coitus or strenuous exercise 2. No folic acid intake (i.e. vitamins) 3. Warn Patient: Poss. rupture need of surgery 4. acetaminophen for pain
Side effects of MTX
Nausea, vomiting, stomatitis,
GI symptoms, dizziness, pneumonitis
(Rarely alopecia or neutropenia, elevated transaminase)
MTX Regimen
Single dose: 50 mg/m2 IM on day 1
Fixed multidose;
1mg/kg IM on day s 1,3,5,7 alternating with folinic acid 0.1
mg/kg IM on days 2,4,6,8
Check ß-hCG on days 4 and 7: > 15%
• If < 15%, consider a repeat MTX dose
• ß-hCG weekly till it falls to non-pregnant level
(< 5-10 mIU/ml)
Who is at risk for MTX failure
Gestational age, higher pre-Rx hCG ; P4 levels,
and (+) fetal heart motion
• Previous ectopic pregnancy regardless of type of
Rx: 20% failure vs. 7% in first-time EP
Persistent Ectopic Pregnancy
Definition: Persistent hCG levels ± symptoms
following conservative therapy
• Prevalence: 3 - 20% after salpingostomy
4 - 6% after MTX Rx
Follow BHCG until negative
Cervical Ectopic
Treatment Options: Multi-dose MTX (with folinic acid rescue) Direct MTX injection Surgical Rx: D&E with large Foley balloon Hysterectomy Uterine artery ligation Uterine Artery embolization
ovarian pregnancy
Will need surgery MTX is ineffective